A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.

Shennan, Andrew

A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. [electronic resource] - BJOG : an international journal of obstetrics and gynaecology Jan 2006 - 65-74 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1470-0328

10.1111/j.1471-0528.2005.00788.x doi


Administration, Oral
Adult
Anti-Infective Agents--therapeutic use
Biomarkers--analysis
Birth Weight
Cervix Uteri--chemistry
Double-Blind Method
Female
Fibronectins--analysis
Gestational Age
Glycoproteins--analysis
Humans
Metronidazole--therapeutic use
Obstetric Labor, Premature--prevention & control
Pregnancy
Pregnancy Complications, Infectious--drug therapy
Pregnancy Outcome
Risk Factors
Tocolytic Agents--therapeutic use
Vagina--chemistry
Vaginosis, Bacterial--drug therapy